Cite
HARVARD Citation
Oudard, S. et al. (n.d.). 433 Decrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC). European journal of cancer. pp. S89-S90. [Online].